Background-Interferon-gamma (IFN-gamma) is an essential cytokine in the reg
ulation of inflammatory responses in autoimmune diseases. Little is known a
bout its role in inflammatory heart disease.
Methods and Results-We showed that IFN-gamma receptor-deficient mice (IFN-g
ammaR(-/-)) on a BALB/c background immunized with a peptide derived from ca
rdiac alpha -myosin heavy chain develop severe myocarditis with high mortal
ity. Although myocarditis subsided in wild-type mice after 3 weeks, IFN-gam
maR(-/-) mice showed persistent disease. The persistent inflammation was ac
companied by vigorous in vitro CD4 T-cell responses and impaired inducible
nitric oxide synthase expression, together with evidence of impaired nitric
oxide production in IFN-gammaR(-/-) hearts. Treatment of wild-type mice wi
th the nitric oxide synthetase inhibitor N-nitro-L-arginine-methyl-ester en
hanced in vitro CD4 T-cell proliferation and prevented healing of myocardit
is.
Conclusions-Our data provide evidence that IFN-gamma protects mice fi om le
thal autoimmune myocarditis by inducing the expression of inducible nitric
oxide synthase followed by the downregulation of T-cell responses.